Found 8 matching trials
A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants PHASE1 TLL018 is developed for treatment of autoimmune and inflammatory diseases i...
Show More Location
Frontage Clinical Services, Inc.
Learn More & Join Trial
A Study of Efficacy and Safety of TLL-018 in CSU Participants PHASE3 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study ...
Show More Status
Active Not Recruiting
Location
Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences
Learn More & Join Trial
A Phase Ib/IIa Study Assessing the Rapid Onset Characteristics of TLL-018 for Moderate-to-Severe CSU With Inadequate Response to Second-Generation H1 Antihistamines PHASE1 The goal of this clinical trial is to evaluate the rapid onset characterist...
Show More Location
The Second People's Hospital of Chengdu
Learn More & Join Trial
Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis PHASE1 This study is a randomized, double-blind, placebo-controlled, multicenter c...
Show More Location
88 Jiefang Road, Shangcheng District, Hangzhou City, Zhejiang Province
Learn More & Join Trial
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHs PHASE2 The goal of this clinical trial is to learn if different doses of TLL-018 w...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis PHASE2 This is an operationally seamless Phase II/III, multicenter, randomized, do...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis PHASE2 This is a Phase 2, multicenter, randomized, double-blinded, parallel dose g...
Show More Learn More & Join Trial
TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs PHASE2 This is a randomized, double-blind, placebo-controlled parallel-group Phase...
Show More Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial